The global microelectronic medical implants market size is
anticipated to reach USD 57.12 billion by 2025, according to a new report by
Grand View Research, Inc., registering a 9.8% CAGR during the forecast period.
Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease,
growing regulatory approvals for new devices and equipment, rising geriatric
population, and introduction of new products are key factors driving market
growth.
Regulatory authorities such as U.S.
FDA have approved several new products and devices to be used by end users,
most of which are equipped with new and innovative technologies that cater to
varied consumer demands. These technologies also increase the ease of use of
these products. For instance, in July 2017, Cochlear Ltd. introduced to the
market a cochlear implant sound processor for iPhone. The U.S. FDA approved
this innovation in June 2017.
Increasing prevalence of diseases such
as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of
microelectronic electronic implants such as defibrillators, pacemakers, and
neurostimulators. As per WHO, approximately 50 million people have epilepsy,
globally, making it one of the most common neurological disorders. The
condition can be treated using neurostimulators that prevent seizures.
Browse full research report on Microelectronic Medical
Implants Market: https://www.grandviewresearch.com/industry-analysis/microelectronic-medical-implants-market
Further key findings from the study
suggest:
- By product, the pacemakers and defibrillators segment
accounted for the largest share in 2016 owing to increasing prevalence of
cardiovascular diseases and rising geriatric population
- RF technology accounted for the largest share in 2016 as it
is employed in wireless implants and helps researchers and clinicians
monitor patient health, capture physiological data, and study normal and
abnormal functioning of the body
- North America commanded the largest share in the
microelectronic medical implants market in 2016 and is expected to
maintain its position over the forecast period. This is owing to favorable
government policies, increasing FDA approvals for various medical devices
in U.S., and high incidence of cardiac diseases
- Key market players include Zimmer Biomet Holdings, Inc.;
Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston
Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke
Philips N.V.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/microelectronic-medical-implants-market/request/rs1
Grand View Research has segmented the global microelectronic
medical implants market on the basis of product, technology, and region:
Microelectronic Medical Implants Product Outlook (Revenue, USD
Million, 2014 - 2025)
- Pacemakers
& Defibrillators
- Neurostimulators
- Implantable
Drug Pumps
- Spinal
Fusion Stimulators
- Cochlear
Implants
- Ocular
Implants
- Others
Microelectronic Medical Implants Technology Outlook (Revenue, USD
Million, 2014 - 2025)
- RF
Technology
- Sensors
- Other
Technology
Microelectronic Medical Implants Regional Outlook (Revenue, USD
Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Mexico
- Middle
East and Africa (MEA)
- South
Africa
- Saudi
Arabia
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment